[1]
|
Jennett, B. (1996) Epidemiology of head injury. Journal of Neurology, Neurosurgery & Psychiatry, 60, 362-369.
doi:10.1136/jnnp.60.4.362
|
[2]
|
Steyerberg, E.W., Mushkudiani, N., Perel, P., Butcher, I., Lu, J., McHugh, G.S., Murray, G.D., Marmarou, A., Roberts, I., Habbema, J.D. and Maas, A.I. (2008) Predicting outcome after traumatic brain injury: Development and international validation of prognostic scores based on admission characteristics. PLOS Medicine, 5, Article ID: e165; Discussion e165,
doi:10.1371/journal.pmed.0050165
|
[3]
|
Barger, S.W. and Van Eldik, L.J. ()1992 S100 beta stimulates calcium fluxes in glial and neuronal cells. The Journal of Biological Chemistry, 267, 9689-9694.
|
[4]
|
Beaudeux, J., Dequen, L. and Foglietti, M. (1999) Pathophysiologic aspects of S100 beta protein: A new biological marker of brain pathology. Annales de Biologie Clinique (Paris), 57, 261-272.
|
[5]
|
Raabe, A., Grolms, C., Keller, M., Dohnert, J., Sorge, O. and Seifert, V. (1998) Correlation of computed tomogramphy findings and serum brain damage markers following severe head injury. Acta Neurochirurgica (Wien), 140, 787-791. doi:10.1007/s007010050180
|
[6]
|
Nylen, K., Ost, M., Csajbok, L.Z., Nilsson, I., Hall, C., Blennow, K., Nellgard, B. and Rosengren, L. (2008) Serum levels of S100B, S100A and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochirurgica (Wien), 150, 221-227. Discussion 227.
doi:10.1007/s00701-007-1489-2
|
[7]
|
Rainey, T., Lesko, M., Sacho, R., Lecky, F. and Childs, C. (2009) Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: Results using a single (24h) time-point. Resuscitation, 80, 341-345.
doi:10.1016/j.resuscitation.2008.11.021
|
[8]
|
Winter, C.D., Iannotti, F., Pringle, A.K., Trikkas, C., Clough, G.F. and Church, M.K. (2002) A microdialysis method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain in vivo. Journal of Neuroscience Methods, 119, 45-50.
doi:10.1016/S0165-0270(02)00153-X
|
[9]
|
Winter, C.D., Pringle, A., Clough, G.F. and Church, M.K. (2004) Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain, 127, 315-320. doi:10.1093/brain/awh039
|
[10]
|
Alber, B., Hein, R., Garbe, C., Caroli, U. and Luppa, P.B. (2005) Multicenter evaluation of the analytical and clinical performance of the Elecsys S100 immunoassay in patients with malignant melanoma. Clinical Chemistry and Laboratory Medicine, 43, 557-563.
doi:10.1515/CCLM.2005.097
|
[11]
|
Lara, D.R., Gama, C.S., Belmonte-de-Abreu, P., Portela, L.V., Goncalves, C.A., Fonseca, M., Hauck, S. and Souza, D.O. (2001) Increased serum S100B protein in schizophrenia: A study in medication-free patients. Journal of Psychiatric Research, 35, 11-14.
doi:10.1016/S0022-3956(01)00003-6
|
[12]
|
Portela, L.V., Tort, A.B., Schaf, D.V., Ribeiro, L., Nora, D.B., Walz, R., Rotta, L.N., Silva, C.T., Busnello, J.V., Kapczinski, F., Goncalves, C.A. and Souza, D.O. (2002) The serum S100B concentration is age dependent. Clinical Chemistry, 48, 950-952.
|
[13]
|
Wiesmann, M., Steinmeier, E., Magerkurth, O., Linn, J., Gottmann, D. and Missler, U. (2010) Outcome prediction in traumatic brain injury: Comparison of neurological status, CT findings and blood levels of S100B and GFAP. Acta Neurologica Scandinavica, 121, No. 3, 2010, pp. 178-185. doi:10.1111/j.1600-0404.2009.01196.x
|
[14]
|
Goyal, A, Carter, M., Niyonkuru, C., Fabio, A., Amin, K., Berger, R.P. and Wagner, A.K. (2012) S100B as a prognostic biomarker in outcome prediction for patients with severe TBI. Journal of Neurotrauma.
doi:10.1089/neu.2012.2579
|
[15]
|
Rodriguez-Rodriguez, A., Egea-Guerrero, J.J., Leon-Justel, A., Cordillo-Escobar, E., Revuelto-Rey, J., Vilches-Arenas, A., Carrillo-Vico, A., Dominguez-Roldan, J.M., Murillo-Cabezas, F. and Guerrero, J.M. (2012) Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults. Clinica Chimica Acta, 414, 228-233.
doi:10.1016/j.cca.2012.09.025
|
[16]
|
Bouvier, D., Eisenmann, N., Gillart, T., Bonneau, J., Guelon, D., Schoeffler, P. and Sapin, V. (2012) Jugular venous and arterial concentrations of serum S100B protein in patients with severe head injury. Annales de Biologie Clinique (Paris), 70,269-275.
|
[17]
|
Thelin, E.P., Johannesson, L.K., Nelson, D.W. and Bellander, B.M. (2013) S100B is an important predictor in traumatic brain injury. Journal of Neurotrauma.
doi:10.1089/neu.2012.2553
|
[18]
|
da Rocha, A.B., Schneider, R.F., de Freitas, G.R., Andre, C., Grivich I., Zanoni, C., Fossa, A., Gehrke, J.T., Pereira, Jotz G., Kaufmann, M., Simon, D. and Regner, A. (2006) Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. Clinical Chemistry and Laboratory Medicine, 44, 1234-1242. doi:10.1515/CCLM.2006.218
|
[19]
|
Dimopolou, I., Korfias, S., Dafni, U., Anthi, A., Psachoulia, C., Julien, G., Sakas, D.E. and Roussos, C. (2003) Protein S100B serum levels in trauma-induced brain death. Neurology, 60, 947-951.
doi:10.1212/01.WNL.0000049931.77887.7F
|
[20]
|
Bloomfield, S.M., McKinney, J., Smith, L. and Brisman, J. (2007) Reliability of S100B in predicting severity of central nervous system injury. Neurocritical Care, 6, 121-138. doi:10.1007/s12028-007-0008-x
|
[21]
|
Mussack, T., Biberthaler, P., Kanz, K.G., Heckl, U., Gruber, R., Linsenmaier, U., Mutscler, W. and Jochum, M. (2002) Immediate S100B and Neuron-Specific Enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock, 18, 395-400.
doi:10.1097/00024382-200211000-00002
|
[22]
|
Anderson, R.E., Hansson, L.O., Nilsson, O., Dijlai-Merzoug, R. and Settergren, G. (2001) High serum S100B levels for trauma patients without head injuries. Neurosurgery, 48, 1255-1258.
|
[23]
|
Savola, O., Pyhtinen, J., Leino, T.K., Siitonen, S., Niemela, O. and Hillbom, M. (2004) Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. Trauma and Acute Care Surgery, 56, 1229-1234.
doi:10.1097/01.TA.0000096644.08735.72
|
[24]
|
Cotton, B.A., Girard, T.D. and Ely, E.W. (2007) Increased levels of serum S100B protein in critically ill patients without brain injury. Shock, 27, 338.
doi:10.1097/01.shk.0000239756.59841.29
|
[25]
|
Routsi, C., Stamataki, E., Nanas, S., Psachoulia, C., Stathpoulos, A., Koroneos, A., Zervon, M., Julian, G. and Roussos, C. (2006) Increased levels of serum S100B protein in critically ill patients without brain injury. Shock, 26, 20-24. doi:10.1097/01.shk.0000209546.06801.d7
|
[26]
|
Yardan, T., Erenler, A.K., Baydin, A., Aydin, K. and Cokluk, C. (2011) Usefulness of S100B protein in neurological disorders. Journal of Pakistan Medical Association, 61, 276-281.
|
[27]
|
Braga, C.W., Martinez, D., Wofchuk, S., Portela, L.V. and Souza, D.O. (2006) S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Medicine, 7, 431-435. doi:10.1016/j.sleep.2005.12.012
|
[28]
|
Mazzini, G.S., Schaf, D.V., Vinade, E.R., Horowitz, E., Bruch, R.S., Brunm, L.M., Goncalves, C.A., Bacal, F., Souza, D.O., Portela, L.V. and Bordignon, S. (2007) Increased S100B serum levels in dilated cardiomyopathy patients. Journal of Cardiac Failure, 13, 850-854.
doi:10.1016/j.cardfail.2007.07.009
|
[29]
|
Yardan, T., Cevik, Y., Donderici, O., Kavalci, C., Yilmaz, F.M., Vural, K., Yuzbasioglu, Y., Gunaydin, Y.K. and Sezer, A.A. (2009) Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning. The American Journal of Emergency Medicine, 27, 838-842. doi:10.1016/j.ajem.2008.04.016
|
[30]
|
Buttner, T., Weyers, S., Postert, T., Sprengelmeyer, R. and Khun, W. (1997) S100 protein: Serum marker of focal brain damage after ischaemic territorial MCA infarction. Stroke, 28, 1961-1965.
doi:10.1161/01.STR.28.10.1961
|
[31]
|
Fassbender, K., Schmidt, R., Schreiner, A., Fatar, M., Muhlhauser, F. and Hennerici, M.D. (1997) Leakage of brain-originated proteins in peripheral blood: Temporal profile and diagnostic value in early ischaemic stroke. Journal of the Neurological Sciences, 148, 101-105.
doi:10.1016/S0022-510X(96)05351-8
|
[32]
|
Herrmann, M., Vos, P., Wunderlich, M.T., de Bruijn, C.H. and Lamers, K.J. (2000) Release of glial tissue-specific protein after acute stroke: A comparative analysis of serum concentrations of protein S100B and glial fibrillary acidic protein. Stroke, 31, 2670-2677.
doi:10.1161/01.STR.31.11.2670
|
[33]
|
Straume-Naesheim, T.M., Anderson, T.E., Jochum, M., Dvorak, J. and Bahr, R. (2008) Minor head trauma in soccer and serum levels of S100B. Neurosurgery, 62, 1297-1305. doi:10.1227/01.neu.0000333301.34189.3d
|
[34]
|
Otto M., Holthusen S., Bahn E., Sohnchen N., Wiltfang J., Geese R., Fischer A. and Reimers C.D. (2000) Boxing and running lead to a rise in serum levels of S100B protein. International Journal of Sports Medicine, 21, 551-555. doi:10.1055/s-2000-8480
|
[35]
|
Dietrich M.O., Tort A.B., Schaf, D.V., Farina M., Goncalves C.A., Souza D.O. andPortela L.V. (2003) Increase in serum S100B protein level after a swimming race. Canadian Journal of Applied Physiology, 28, 710-716.
doi:10.1139/h03-054
|
[36]
|
Gonzclez-Mao, M.C., Reparaz-Andrade, A., Del Campo-Perez, V., Alvarez-Garcia, E., Vara-Perez, C. and Andrade-Olivie, M.A. (2011) Model predicting survival/exitus after traumatic brain injury: Biomarker S100B 24h. Clinical Laboratary, 57, 587-597.
|
[37]
|
Kleindienst, A. and Bullock, R.R. (2006) A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. Journal of Neurotrauma, 23, 1185-1200.
doi:10.1089/neu.2006.23.1185
|
[38]
|
Korn, A., Golan, H., Melamed, I., Pascual-Marqui, R. and Friedman, A. (2005) Focal cortical dysfunction and blood-brain barrier disruption in patients with post-concussion syndrome. Journal of Clinical Neuro-Physiology, 22, 1-9.
doi:10.1097/01.WNP.0000150973.24324.A7
|
[39]
|
Tomkins, O., Shelef, I., Kaizerman, I., Eliushin, A., Misk, Z.A., Gidon, M., Cohen,A., Zumsteg, D. and Friedman, A. (2008) Blood-brain barrier disruption in post-traumatic epilepsy. Journal of Neurosurgery & Psychiatry with Practical Neurology, 79, 774-777.
doi:10.1136/jnnp.2007.126425
|
[40]
|
Shlosberg, D., Benifla, M., Kaufer. D. and Friedman, A. (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nature Reviews. Neurology, 6, 393-403. doi:10.1038/nrneurol.2010.74
|
[41]
|
Andersson, M., Alvarez-Cermeno, J., Bernardi, G., Cogato, I., Fredman, P., Frederiksen, J., Fredrikson, S., Gallo, P., Grimaldi, L.M., Gronning, M., Keir, G., Lamers, K., Link, H., Magalhaes, A., Massaro, A.R., Ohman, S., Reiber, H., Ronnback, L., Schluep, M., Schuller, E., Sindic, C.J.M., Thompson, E.J., Trojano, M. and Wurster, U. (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report. Journal of Neurology, Neurosurgery & Psychiatry with Practical Neurology, 57, 897-902.doi:10.1136/jnnp.57.8.897
|
[42]
|
Reiber, H. and Peter, J.B. (2001) Cerebrospinal fluid analysis: Disease-related data patterns and evaluation programs. Journal of Neurological Sciences, 184, 101-122.
|
[43]
|
Blyth, B.J., Farhavar, A., Gee, C., Hawthorn, B., He, H., Nayak, A., Stocklein, V. and Bazarian, J.J. (2009) Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. Journal of Neurotrauma, 26, 1497-1507. doi:10.1089/neu.2008.0738
|
[44]
|
Bellander, B.M., Olafsson, I.H., Ghatan, P.H., Skejo, B.H.P., Hansson, L.O., Wanecek, M. and Svensson, M.A. (2011) Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B. Acta Neurochirurgica, 153, 90-100. doi:10.1007/s00701-010-0737-z
|
[45]
|
Dayon, L., Turck, N., Garcia-Berrocoso, T., Walter, N., Burkhard, P.R., Vilalta, A., Sahuquillo, J., Montaner, J. and Sanchez, J.C. (2011) Brain extracellular fluid protein changes in acute stroke patients. Journal of Proteome Research, 10, 1043-1051. doi:10.1021/pr101123t
|
[46]
|
Sen, J., Belli, A., Petzold, A., Russo, S., Keir, G., Thompson, E.J., Smith, M. and Kitchen, N. (2005) Extracellular fluid S100B in the injured brain: A future surrogate marker of acute brain injury? Acta Neurochirurgica, 147, 897-900. doi:10.1007/s00701-005-0526-2
|
[47]
|
Clough, G.F., Boutsiouki, P., Church, M.K. and Michel, C.C. (2002) Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. The Journal of Pharmacology and Experimental Therapeutics, 302, 681-686.doi:10.1124/jpet.102.035634
|
[48]
|
Cserr, H.F. (1971) Physiology of the choroid plexus. Physiological Reviews, 51, 273-311.
|
[49]
|
Kirchhoff, C., Buhmann, S., Braunstein, V., Leidel, B.A., Vogel, T., Kreimeier, U., Mutschler, W. and Biberthaler, P. (2008) Cerebrospinal S100-B: A potential marker for progressive intracranial haemorrhage in patients with severe traumatic brain injury. European Journal of Medical Research, 13, 511-516.
|
[50]
|
Bohmer, A.E., Oses, J.P., Schmidt, A.P., Peron, C.S., Krebs, C.L., Oppitz, P.P., D’Avila, T.T., Souza, D.O., Portela, L.V. and Stefani, M.A. (2011) Neuro-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery, 68, 1624-1630.
doi:10.1227/NEU.0b013e318214a81f
|
[51]
|
Kliendienst, A., Schmidt, C., Parsch, H., Emtmann, I., Xu, Y. and Buchfelder, M. (2010) The passage of S100B from brain to blood is not specifically related to blood-brain barrier intregrity. Cardiovascular Psychiatry and Neurology, 2010, Article ID: 801295, 8 Pages.
doi:10.1155/2010/801295
|
[52]
|
Stenken, J.A., Church, M.K., Gill, C.A. and Clough, G.F. (2010) How minimally invasive is microdialysis sampling? A cautionary note for cytokine collection in human skin and other clinical studies. AAPS Journals, 12, 73-78.
doi:10.1208/s12248-009-9163-7
|
[53]
|
Benveniste, H. and Diemer, N.H. (1987) Cellular reactions to implantation of a microdialysis tube in the rat hippocampus. Acta Neuropathologica, 74, 234-238.
doi:10.1007/BF00688186
|
[54]
|
Landolt, H., Langemann, H. and Alessandri, B. (1996) A concept for the introduction of cerebral microdialysis in neurointensive care. Acta Neurochirurgica, 67, S31-S36.
|
[55]
|
Benveniste, H. and Huttemeier, P.C. (1990) Microdialysis—Theory and application. Progress in Neurobiology, 35, 195-215. doi:10.1016/0301-0082(90)90027-E
|
[56]
|
Lonnroth, P. and Smith, U. (1990) Microdialysis–A novel technique for clinical investigations. Journal of Internal Medicine, 227, 295-300.
doi:10.1111/j.1365-2796.1990.tb00163.x
|